Loss of IFN-gamma 3’untranslated region AU-rich element affects B220+ B cell and plasmacytoid dendritic cell populations in novel murine lupus model (161.3)

Interferon-gamma (IFN-g) is a key player in immunoregulation, inflammation and autoimmunity. We created a mouse with a162 nt deletion of an AU-rich element (ARE) region in the 3’UTR of the IFN-g gene. The ARE-deleted (ARE-Del) mice have chronic circulating serum IFN-g levels and develop a lupus-like...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of immunology (1950) Vol. 188; no. 1_Supplement; pp. 161 - 161.3
Main Authors Hodge, Deborah, Berthet, Cyril, Coppola, Vincenzo, Shirota, Hidekazu, Reynolds, Della, Klinman, Dennis, Young, Howard
Format Journal Article
LanguageEnglish
Published 01.05.2012
Online AccessGet full text

Cover

Loading…
More Information
Summary:Interferon-gamma (IFN-g) is a key player in immunoregulation, inflammation and autoimmunity. We created a mouse with a162 nt deletion of an AU-rich element (ARE) region in the 3’UTR of the IFN-g gene. The ARE-deleted (ARE-Del) mice have chronic circulating serum IFN-g levels and develop a lupus-like disease characterized by DNA and nuclear antigen-specific autoantibodies and glomerulonephritis. B220+ B cells and plasmacytoid dendritic cells (pDCs) play a prominent role in systemic lupus erythematosus (SLE). We find alterations in both cell types. Greater B cell percentages are found in lymph nodes and thymus with a concomitant reduction in spleen. The B cells have an activated phenotype with increased CD69 and/or CD86 expression. The ARE-Del thymic B cell population is partially composed of B1a and B1b B cells and is correlated with increased thymic mRNA expression of the B cell chemoattractant, CXCL13. Splenic B cells down-regulate CD23 and CD21 with no change in surface markers CD19, B220, IgM, and IgD. The percentage of CD11c+, pDCA1+, B220+ Siglec H+ pDCs is increased in bone marrow and spleens from AU-deleted mice. Current studies are underway to further characterize the pDC population and to investigate expression of bone marrow-specific factors important for pDC development. Overall, these data demonstrate that low chronic IFN-g levels are sufficient to alter the phenotype and potentially the development of cells important for SLE disease onset and progression.
ISSN:0022-1767
1550-6606
DOI:10.4049/jimmunol.188.Supp.161.3